Sutha K. John

Medicine · Indiana University

Bone health and treatments Cytokine Signaling Pathways and Interactions Alzheimer's disease research and treatments Neuroinflammation and Neurodegeneration Mechanisms Bone health and osteoporosis research

Publications

Citations

1,090

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 1997

Research summary

AI-generated

Sutha K. John studies bone biology and how it interacts with muscle health and cancer. The research uses animal models and cell studies to examine conditions like bone loss from radiation, high-fat diets, or breast-cancer treatments, and how these affect bone quality, muscle strength, and tumor spread. A recurring focus is the link between bone, the bone marrow environment, and breast cancer progression.

Bone health and bone lossMuscle function and bone-muscle interactionBreast cancer progression and metastasisVitamin D receptor signalingCancer treatment effects on bone

Publication activity has been intermittent over the last decade, with quiet years but a notable burst of output in 2023.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence

Publications per year over the last 10 years — averaging 1.8/year recently

Recent publications

Zoledronic acid improves bone quality and muscle function in a high bone turnover state
bioRxiv (Cold Spring Harbor Laboratory) · 2023
Single-Limb Irradiation Induces Local and Systemic Bone Loss in a Murine Model
UNC Libraries · 2020
Impact of a Long-Term High Fat Diet on Bone Microarchitecture and Muscle Structure in Adult Male and Female Normal Mice
Proceedings of IMPRS · 2019
Exposure to Adipose-Enriched Bone Marrow Increased Breast Cancer Cell Expression of Genes that Drive Tumor Metastasis
Proceedings of IMPRS · 2019
The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm
Oncotarget · 2017
The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm
PMC · 2017
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness <i>in vivo</i>
Oncotarget · 2016

Publishes in

bioRxiv (Cold Spring Harbor Laboratory)×3
Proceedings of IMPRS×3
Oncotarget×2
Frontiers in Immunology×1
The Journal of Experimental Medicine×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile